Qiuyan Xiao1, Shouyan Zheng, Lili Zhou, Luo Ren, Xiaohong Xie, Yu Deng, Daiyin Tian, Yao Zhao, Zhou Fu, Tingyu Li, Ailong Huang, Enmei Liu. 1. From the *Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing, Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China; †Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China; and ‡Key Laboratory of Molecular Biology of Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China.
Abstract
BACKGROUND: Human rhinovirus (HRV) is not only responsible for at least one-half of all common colds but also associated with bronchitis, bronchiolitis, pneumonia and acute asthma exacerbation. However, the impact of different HRV types and viral load on disease severity has not been thoroughly elucidated. METHODS: From January 2012 to September 2014, 1742 nasopharyngeal aspirate specimens from hospitalized children with lower respiratory tract infections were analyzed by quantitative HRV-specific real-time polymerase chain reaction. RESULTS: Among these 1742 children, HRV (407/1742, 23%) was the second most common viral agent after respiratory syncytial virus. HRV-A, HRV-B, HRV-C and HRV untyped were detected in 229 (56%), 27 (7%), 100 (25%) and 51 (13%) specimens, respectively. Children except who experienced wheezing were more common in the HRV-C detection group than in the HRV-A detection group; there were no other significant differences between the 2 groups, including the percent of children diagnosed with severe diseases. Logistic regression models demonstrated that there was no difference in disease severity among HRV types. In HRV-A detection group, in children younger than 2 years, the viral load was higher in the severe group than in the nonsevere group; but in the HRV-C detection group, there was no difference. CONCLUSIONS: HRV was frequently present in hospitalized children with lower respiratory tract infections in Chongqing, China. The disease severity for HRV-C and HRV-A was similar. A high load of HRV-A in the lower respiratory tract might be connected with disease severity in children younger than 2 years.
BACKGROUND:Human rhinovirus (HRV) is not only responsible for at least one-half of all common colds but also associated with bronchitis, bronchiolitis, pneumonia and acute asthma exacerbation. However, the impact of different HRV types and viral load on disease severity has not been thoroughly elucidated. METHODS: From January 2012 to September 2014, 1742 nasopharyngeal aspirate specimens from hospitalized children with lower respiratory tract infections were analyzed by quantitative HRV-specific real-time polymerase chain reaction. RESULTS: Among these 1742 children, HRV (407/1742, 23%) was the second most common viral agent after respiratory syncytial virus. HRV-A, HRV-B, HRV-C and HRV untyped were detected in 229 (56%), 27 (7%), 100 (25%) and 51 (13%) specimens, respectively. Children except who experienced wheezing were more common in the HRV-C detection group than in the HRV-A detection group; there were no other significant differences between the 2 groups, including the percent of children diagnosed with severe diseases. Logistic regression models demonstrated that there was no difference in disease severity among HRV types. In HRV-A detection group, in children younger than 2 years, the viral load was higher in the severe group than in the nonsevere group; but in the HRV-C detection group, there was no difference. CONCLUSIONS:HRV was frequently present in hospitalized children with lower respiratory tract infections in Chongqing, China. The disease severity for HRV-C and HRV-A was similar. A high load of HRV-A in the lower respiratory tract might be connected with disease severity in children younger than 2 years.
Authors: Vishal Parikh; Jacqueline Scala; Riva Patel; Corinne Corbi; Dennis Lo; Yury A Bochkov; Joshua L Kennedy; Richard C Kurten; Stephen B Liggett; James E Gern; Cynthia J Koziol-White Journal: Am J Respir Cell Mol Biol Date: 2020-03 Impact factor: 6.914
Authors: Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews Journal: Clin Microbiol Rev Date: 2018-12-12 Impact factor: 26.132
Authors: Leigh M Howard; Monika Johnson; Ana I Gil; Marie R Griffin; Kathryn M Edwards; Claudio F Lanata; John V Williams; Carlos G Grijalva Journal: Open Forum Infect Dis Date: 2016-01-13 Impact factor: 3.835
Authors: Kim Tien Ng; Jack Bee Chook; Xiang Yong Oong; Yoke Fun Chan; Kok Gan Chan; Nik Sherina Hanafi; Yong Kek Pang; Adeeba Kamarulzaman; Kok Keng Tee Journal: Sci Rep Date: 2016-10-10 Impact factor: 4.379
Authors: Jérôme O Wishaupt; Tjeerd van der Ploeg; Ronald de Groot; Florens G A Versteegh; Nico G Hartwig Journal: BMC Infect Dis Date: 2017-01-11 Impact factor: 3.090
Authors: Ajda Praznik; Neža Vinšek; Ana Prodan; Vanja Erčulj; Marko Pokorn; Tatjana Mrvič; Darja Paro; Uroš Krivec; Franc Strle; Miroslav Petrovec; Marta Žnidaršič Eržen; Štefan Grosek Journal: Influenza Other Respir Viruses Date: 2018-08-09 Impact factor: 4.380
Authors: Annamari Koistinen; Minna Lukkarinen; Riitta Turunen; Tytti Vuorinen; Tero Vahlberg; Carlos A Camargo; James Gern; Olli Ruuskanen; Tuomas Jartti Journal: Pediatr Allergy Immunol Date: 2017-08-06 Impact factor: 6.377